Trials / Completed
CompletedNCT00315575
Memory Imaging of Normal Aging
BOLD and Perfusion fMRI of Alzheimer's Disease Risk
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (estimated)
- Sponsor
- National Institute on Aging (NIA) · NIH
- Sex
- All
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to develop imaging techniques that can distinguish functional brain changes in people at high risk for dementia years prior to onset of clinical memory problems from those with normal changes of aging.
Detailed description
The overall goals of this project are to identify consistent patterns of variance in brain function in patients at risk for Alzheimer's Disease by using APOE ε4 as a marker for disease risk. The activation Blood Oxygen Level Dependency (BOLD) signal will be compared to both resting and activation perfusion signals to assess the variability of cerebral blood flow as it relates to the BOLD signal. Each participant will be imaged on a 3T MRI scanner while performing an associate episodic memory task. A total of 90 individuals will be recruited for this study. Participants will be non-demented, right handed, adults with or without at least one APOE ε4 allele. Groups will be split as follows: A) ages 25-39: non-ε4 (n=15); B) ages 25-39: +ε4 (n=15); C) ages 40-49: non-ε4 (n=15); D) ages 40-49: +ε4 (n=15);.E) ages 50-65: non-ε4: F) ages 50-65: +ε4 (n=15). These groups will be matched for mean age, mean years of education, gender distribution, as well as the presence or absence of a family history of AD in a first degree relative. There will be 2 scanning sessions for each participant. Scan session #1 and Scan session #2 will be acquired within 2 weeks of each other and will take approximately one hour each.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | BOLD and Perfusion brain MRI | Blood oxygenation and perfusion functional MRI performed twice, two weeks apart; each scan lasts 1 hour |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2006-04-18
- Last updated
- 2009-01-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00315575. Inclusion in this directory is not an endorsement.